LOGIN  |  REGISTER

Recent Insider Transactions - Janux Therapeutics (NASDAQ: JANX)

Follow NASDAQ:JANX Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ JANX Janux Therapeutics
RA CAPITAL MANAGEMENT, L.P. / director, 10 percent owner:
03/04/2024
Buy
$0.001
1.40M
$1K
1.40M
NASDAQ JANX Janux Therapeutics
Winter Charles M. / officer: Chief Technical Officer
01/02/2024
Buy
$11.02
111,000
$1.223M
111,000
NASDAQ JANX Janux Therapeutics
Robinson Byron / officer: Chief Strategy Officer
01/02/2024
Buy
$11.02
151,500
$1.670M
151,500
NASDAQ JANX Janux Therapeutics
Reardon Tighe / 10 percent owner, officer: Acting Chief Financial Officer
01/02/2024
Buy
$11.02
157,000
$1.730M
157,000
NASDAQ JANX Janux Therapeutics
Meyer Andrew Hollman / officer: Chief Business Officer
01/02/2024
Buy
$11.02
105,000
$1.157M
105,000
NASDAQ JANX Janux Therapeutics
Campbell David Alan / director, officer: President and CEO
01/02/2024
Buy
$11.02
356,500
$3.929M
356,500
NASDAQ JANX Janux Therapeutics
DiRaimondo Thomas / officer: Chief Scientific Officer
01/02/2024
Buy
$11.02
147,000
$1.620M
147,000
NASDAQ JANX Janux Therapeutics
DiRaimondo Thomas / officer: Chief Scientific Officer
01/01/2024
Sell
$0.59
153,720
$91K
0
NASDAQ JANX Janux Therapeutics
DiRaimondo Thomas / officer: Chief Scientific Officer
01/01/2024
Sell
$4.21
140,910
$593K
0
NASDAQ JANX Janux Therapeutics
DiRaimondo Thomas / officer: Chief Scientific Officer
01/01/2024
Sell
$10.59
256,200
$2.712M
0
NASDAQ JANX Janux Therapeutics
DiRaimondo Thomas / officer: Chief Scientific Officer
01/01/2024
Sell
$20.24
23,970
$485K
0
NASDAQ JANX Janux Therapeutics
DiRaimondo Thomas / officer: Chief Scientific Officer
01/01/2024
Sell
$14.02
70,000
$981K
0
NASDAQ JANX Janux Therapeutics
Reardon Tighe / 10 percent owner, officer: Acting Chief Financial Officer
11/13/2023
Buy
$5.87
849,854
$4.989M
849,854
NASDAQ JANX Janux Therapeutics
Lichter Jay / director, 10 percent owner:
11/13/2023
Buy
$5.87
849,854
$4.989M
849,854
NASDAQ JANX Janux Therapeutics
Avalon Ventures XI, L.P. / 10 percent owner
11/13/2023
Buy
$5.87
849,854
$4.989M
849,854
NASDAQ JANX Janux Therapeutics
RA CAPITAL MANAGEMENT, L.P. / director, 10 percent owner:
07/19/2023
Buy
$12.46
495,008
$6.168M
8.12M
NASDAQ JANX Janux Therapeutics
RA CAPITAL MANAGEMENT, L.P. / director, 10 percent owner:
07/19/2023
Buy
$0.001
503,226
$503
503,226
NASDAQ JANX Janux Therapeutics
RA CAPITAL MANAGEMENT, L.P. / director, 10 percent owner:
06/14/2023
Buy
$13.22
12,500
$165K
12,500
NASDAQ JANX Janux Therapeutics
Lichter Jay / director, 10 percent owner:
06/14/2023
Buy
$13.22
12,500
$165K
12,500
NASDAQ JANX Janux Therapeutics
McNulty Alana B. / director
06/14/2023
Buy
$13.22
12,500
$165K
12,500
NASDAQ JANX Janux Therapeutics
Simson Jake / director
06/14/2023
Buy
$13.22
12,500
$165K
12,500
NASDAQ JANX Janux Therapeutics
Kung Winston / director
06/14/2023
Buy
$13.22
12,500
$165K
12,500
NASDAQ JANX Janux Therapeutics
Gujrathi Sheila / director
06/14/2023
Buy
$13.22
12,500
$165K
12,500
NASDAQ JANX Janux Therapeutics
CAPPS VICKIE L / director
06/14/2023
Buy
$13.22
12,500
$165K
12,500
NASDAQ JANX Janux Therapeutics
Barrett Ronald W / director
06/14/2023
Buy
$13.22
12,500
$165K
12,500
NASDAQ JANX Janux Therapeutics
Winter Charles M. / officer: Chief Technical Officer
01/01/2023
Sell
$20.24
78,000
$1.579M
0
NASDAQ JANX Janux Therapeutics
Kung Winston / director
09/21/2022
Buy
$13.54
30,000
$406K
30,000
NASDAQ JANX Janux Therapeutics
Kung Winston / director
09/21/2022
Buy
$13.54
9,375
$127K
9,375
NASDAQ JANX Janux Therapeutics
Thompson Peter A. / director
06/14/2022
Buy
$10.73
12,500
$134K
12,500
NASDAQ JANX Janux Therapeutics
Gujrathi Sheila / director
06/14/2022
Buy
$10.73
12,500
$134K
12,500
NASDAQ JANX Janux Therapeutics
Lichter Jay / director, 10 percent owner:
06/14/2022
Buy
$10.73
12,500
$134K
12,500
NASDAQ JANX Janux Therapeutics
RA CAPITAL MANAGEMENT, L.P. / director, 10 percent owner:
06/14/2022
Buy
$10.73
12,500
$134K
12,500

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous